Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 66
Filter
2.
Hepatogastroenterology ; 61(130): 469-74, 2014.
Article in English | MEDLINE | ID: mdl-24901164

ABSTRACT

BACKGROUND/AIMS: Soft pancreases are susceptible to developing pancreatic fistula following pancreaticoduodenectomy. To reduce the incidence of pancreatic fistula after pancreaticoduodenectomy in patients with a soft pancreas, we developed a triple secured technique. In this study, we describe the details of this technique and also report on the postoperative outcomes. METHODOLOGY: The triple secured technique employed an ultrasonic dissector for pancreatic transection with skeletonizing and ligating of the small pancreatic branch ducts, duct-invagination or duct-to-mucosa anastomosis for main pancreatic duct management, and, finally, four large stitches between the pancreatic stump parenchyma and the jejunal seromuscular layer to prevent minor pancreatic leakage. A total of 28 consecutive patients with a soft pancreas who underwent pancreaticoduodenectomy using our technique were included in this study. RESULTS: Postopetrative complications occurred in 16 patients. Grade B pancreatic fistula developed in 6 patients. However, no grade C pancreatic fistula occurred in this series. Neither any reoperation nor in-hospital mortality was observed in this series. CONCLUSIONS: Our triple secured technique after pancreaticoduodenectomy was feasible and safe, with an acceptable rate of grade B pancreatic fistula and no grade C pancreatic fistula for patients with a soft pancreas.


Subject(s)
Pancreatic Ducts/surgery , Pancreaticoduodenectomy/adverse effects , Pancreaticoduodenectomy/methods , Suture Techniques , Adult , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Jejunum/surgery , Male , Middle Aged , Pancreatic Diseases/surgery , Pancreatic Fistula/prevention & control , Postoperative Complications/prevention & control , Treatment Outcome
3.
Int J Lab Hematol ; 32(4): 419-26, 2010 Aug 01.
Article in English | MEDLINE | ID: mdl-19968719

ABSTRACT

Nasal natural killer (NK)-cell lymphoma was resistant to various antitumor agents. Although high expression of p-glycoprotein has been reported, other molecular mechanism of the chemo-resistance is largely unknown. Activation of STAT3 and expression of major apoptosis-related proteins Bcl-2, Bcl-x, and Mcl-1 were analyzed by immunohistochemistry. Effects of STAT3 inhibitor AG490 on NK-YS cell line were analyzed by Western blotting and flow cytometric apoptosis assay. STAT3 was activated in six of the nine nasal NK-cell lymphomas (67%). In contrast, STAT3 activation was detected in 35% of diffuse large B-cell lymphoma (DLBCL) and in 10% of follicular lymphoma (FL). Frequent activation of STAT3 was significantly correlated with Mcl-1 expression in nasal NK-cell lymphoma, i.e., Mcl-1 was positive in five of six STAT3-active cases and negative in all three STAT3-inactive ones. In DLBCL, not only six out of seven STAT3-active cases (86%) but also eight out of thirteen STAT3-inactive cases (62%) were positive for Mcl-1 expression. Latent membrane protein-1 was positive in four nasal NK-cell lymphomas, among which three cases showed intermediate STAT3 activation. Inhibition of STAT3 activation by JAK inhibitor AG490 decreased Mcl-1 expression and induced apoptosis in STAT3-active NK-YS cells. Serum starvation rather increased the Mcl-1 level in NK-YS cells, and this effect was also canceled by AG490. These results suggest that activation of STAT3-Mcl-1 axis may play a role in the chemotherapy resistance of nasal NK-cell lymphoma. The pathway may be one of the future therapeutic targets of this intractable disease.


Subject(s)
Lymphoma, Extranodal NK-T-Cell/metabolism , Proto-Oncogene Proteins c-bcl-2/biosynthesis , STAT3 Transcription Factor/metabolism , Anticarcinogenic Agents/pharmacology , Apoptosis/drug effects , Blotting, Western , Cell Line, Tumor , Drug Screening Assays, Antitumor , Flow Cytometry , Humans , Immunohistochemistry , Lymphoma, Extranodal NK-T-Cell/drug therapy , Myeloid Cell Leukemia Sequence 1 Protein , Proto-Oncogene Proteins c-bcl-2/antagonists & inhibitors , STAT3 Transcription Factor/antagonists & inhibitors , Tyrphostins/pharmacology
5.
Oncogene ; 27(22): 3091-101, 2008 May 15.
Article in English | MEDLINE | ID: mdl-18071310

ABSTRACT

Checkpoint protein Chk1 has been identified as an Hsp90 client. Treatment with 100 nM geldanamycin (GM) for 24 h markedly reduced the Chk1 amount in Jurkat and ML-1 leukemia cell lines. Because Chk1 plays a central role in G2 checkpoint, we added GM to G2-arrested Jurkat and HL-60 cells pretreated with 50 nM doxorubicin for 24 h. GM slowly released both cell lines from doxorubicin-induced G2 arrest into G1 phase. GM also abrogated ICRF-193-induced decatenation G2 checkpoint in Jurkat and HL-60 cells. Western blot analysis showed that addition of GM attenuates doxorubicin- and ICRF-193-induced Chk1 phosphorylation at Ser345. GM, however, failed to abrogate G2 arrest in p53-positive ML-1 cells maybe due to the p21 induction. GM released HeLa cells from doxorubicin-induced G2 arrest but trapped them at M phase. Flow cytometric analysis showed that addition of GM converted doxorubicin-induced necrosis into apoptosis in Jurkat cells. Colony assay indicated that although GM has a weak cytotoxic effect as a single agent, it dramatically intensifies the cytotoxicity of doxorubicin and ICRF-193 in Jurkat and HL-60 cells. These results suggest that abrogation of G2 checkpoint by GM may play a central role in sensitizing p53-negative tumor cells to DNA-damaging and decatenation-inhibiting agents.


Subject(s)
Benzoquinones/pharmacology , Cell Proliferation/drug effects , G2 Phase/drug effects , Lactams, Macrocyclic/pharmacology , Leukemia/pathology , Protein Kinases/metabolism , Antibiotics, Antineoplastic/pharmacology , Cell Death/drug effects , Cell Line, Tumor , Checkpoint Kinase 1 , DNA Damage/drug effects , DNA Damage/physiology , Diketopiperazines , Dose-Response Relationship, Drug , Down-Regulation/drug effects , Doxorubicin/pharmacology , Drug Resistance, Neoplasm/drug effects , Genes, p53 , HL-60 Cells , HSP90 Heat-Shock Proteins/antagonists & inhibitors , HeLa Cells , Humans , Jurkat Cells , Leukemia/genetics , Leukemia/metabolism , Piperazines/pharmacology
6.
Clin Exp Allergy ; 35(10): 1327-33, 2005 Oct.
Article in English | MEDLINE | ID: mdl-16238792

ABSTRACT

BACKGROUND: Although it is thought that both Th1- and Th2-type inflammations are involved in the pathogenesis of atopic dermatitis (AD), it is controversial which immune response is more involved in regulating the clinical severity of AD. We recently found that the squamous cell carcinoma antigens 1 (SCCA1) and SCCA2 are novel biomarkers of bronchial asthma, downstream of IL-4 and IL-13. OBJECTIVE: We examined whether SCCA1 and SCCA2 could also serve as biomarkers of AD, reflecting its Th2-type immune responses, and whether the expression level of SCCA was correlated with clinical severity of AD. METHOD: We compared the expression of SCCA1 and SCCA2 at the mRNA and protein levels in both involved and uninvolved skin of AD patients and in normal control skin. We next analysed induction of SCCA by IL-4 or IL-13 in keratinocytes. Finally, we compared the serum level of SCCA with laboratory parameters reflecting Th2-type inflammation and clinical severity in AD patients. RESULTS: SCCA1 and SCCA2 were highly expressed in involved skin of AD patients, compared with their uninvolved skin, at both mRNA and protein levels. SCCA protein was dominantly expressed in suprabasal keratinocytes in the epidermis of AD patients. Either IL-4 or IL-13, but not IFN-gamma or TNF, induced production of SCCA in keratinocytes. These result suggest that SCCA is induced in AD skin, probably due to direct actions of IL-4 and/or IL-13 on keratinocytes. Serum levels of SCCA were well correlated with eosinophil numbers and serum lactate dehydrogenase levels, and weakly with serum IgE levels, in AD patients. Furthermore, serum levels of SCCA were strongly correlated with clinical severity. CONCLUSIONS: Th2-type inflammation dominantly regulates the clinical severity of AD, and SCCA is a relevant biomarker of AD, reflecting both Th2-type inflammation and clinical severity.


Subject(s)
Antigens, Neoplasm/metabolism , Dermatitis, Atopic/diagnosis , Serpins/metabolism , Adult , Antigens, Neoplasm/genetics , Biomarkers/metabolism , Cells, Cultured , Dermatitis, Atopic/immunology , Dermatitis, Atopic/pathology , Humans , Interleukin-13/immunology , Interleukin-4/immunology , Keratinocytes/immunology , Polymerase Chain Reaction/methods , RNA, Messenger/genetics , Serpins/genetics , Severity of Illness Index , Skin/immunology , Th2 Cells/immunology , Up-Regulation/immunology
8.
Br J Dermatol ; 148(1): 117-21, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12534604

ABSTRACT

BACKGROUND: Adult atopic dermatitis (AD) in Japan has become a significant social problem, with as many as one-third of adult patients with severe AD absenting themselves from work or classes due to aggravation of the disease. Reports of such patients have become increasingly common in recent years. Despite the pressing need for epidemiological studies to clarify the prevalence and distribution of AD and to determine its aetiology, no previous research has been carried out on the prevalence of AD within the adult population in Japan. OBJECTIVES: To clarify the prevalence of adult AD in Japan, using the U.K. Working Party's diagnostic criteria. METHODS: The subjects of this study were mostly government officials or their family members visiting the Medical Center of Health Science, Toranomon Hospital in Tokyo for annual health check-ups in the period from September 1997 to August 1998. Questionnaires completed by 10 762 persons (8076 men and 2686 women) aged 30 years or above were analysed. The questionnaire consisted of 14 questions on allergic disease. The U.K. Working Party's diagnostic criteria were used after translation into Japanese. Three types of prevalence were used as indicators of prevalence: point, 1-year and lifetime prevalence. RESULTS: The point prevalence, 1-year prevalence and lifetime prevalence of AD in Japanese adults were 2.9%, 3.0% and 3.3%, respectively. No significant statistical differences were observed between the sexes or among age groups within each sex. The survey indicated that 88.6% of those who had ever had AD were currently affected by active AD, while 93.4% of those who had had at least one episode of AD in the past had experienced an episode over the previous year. CONCLUSIONS: This study gives the first indication of the prevalence of adult AD among the Japanese, based on the U.K. criteria. Both the internal and external validity of this study are believed to be high; it would be safe to conclude that the 1-year prevalence of AD in Japanese adult populations living in urban areas is 3.0%.


Subject(s)
Dermatitis, Atopic/epidemiology , Adult , Age Distribution , Aged , Female , Humans , Male , Middle Aged , Prevalence , Sex Distribution , Tokyo/epidemiology
9.
Aliment Pharmacol Ther ; 16 Suppl 2: 240-4, 2002 Apr.
Article in English | MEDLINE | ID: mdl-11966548

ABSTRACT

BACKGROUND: The relationship between H. pylori infection and body mass indices is controversial. AIM: To investigate the relationship between H. pylori infection and body indices, and to examine the effect of H. pylori eradication therapy on body indices. METHODS: Nine-hundred and thirty-two employees of an industrial corporation were examined for H. pylori infection and body mass indices. Three hundred and two H. pylori-positive cases diagnosed with chronic gastritis by upper gastrointestinal endoscopy or radiography underwent eradication therapy. Body mass indices, serum total cholesterol levels and symptom scores were obtained before and at 12 months after eradication therapy. RESULTS: There was no significant difference in body weight, body mass index (BMI) or serum total cholesterol level between the H. pylori-positive and H. pylori-negative groups. However, body weight and BMI increased significantly 12 months after eradication of H. pylori infection. In contrast, there was no significant difference in body weight and BMI 12 months after eradication therapy in the non-eradication group. Serum total cholesterol levels did not change after eradication therapy in either the eradication or non-eradication groups. CONCLUSION: Eradication of H. pylori infection induced an increase in BMI in industrial workers with chronic gastritis in Japan.


Subject(s)
Body Mass Index , Helicobacter Infections/complications , Helicobacter pylori/isolation & purification , Adult , Female , Gastritis/complications , Gastritis/physiopathology , Helicobacter Infections/microbiology , Helicobacter Infections/physiopathology , Humans , Male , Middle Aged
10.
Nihon Ishinkin Gakkai Zasshi ; 42(4): 217-8, 2001.
Article in Japanese | MEDLINE | ID: mdl-11704749

ABSTRACT

We compared cutaneous colonization levels of Malassezia species in patients with AD and healthy subjects using nested PCR. Malassezia-specific DNA was detected in all 32 of the patients with AD. M. globosa and M. restricta were detected in approximately 90% of these patients, with M. furfur and M. sympodialis being detected in approximately 40% of the cases. In healthy subjects, Malassezia DNA was detected in 78% of the samples, M. globosa, M. restricta and M. sympodialis were detected at frequencies ranging from 44 to 61%, and M. furfur was found in 11% of healthy subjects. Our results suggest that M. furfur, M. globosa, M. restricta and M. sympodialis are common inhabitants of the skin of both AD patients and healthy subjects, while the skin microflora of patients with AD shows more diversity than that of healthy subjects.


Subject(s)
Dermatitis, Atopic/microbiology , Malassezia/isolation & purification , Skin/microbiology , Humans , Malassezia/genetics , Microbiological Techniques , Polymerase Chain Reaction/methods
11.
J Clin Microbiol ; 39(10): 3486-90, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11574560

ABSTRACT

Members of the genus Malassezia, lipophilic yeasts, are considered to be one of the exacerbating factors in atopic dermatitis (AD). We examined variation in cutaneous colonization by Malassezia species in AD patients and compared it with variation in healthy subjects. Samples were collected by applying transparent dressings to the skin lesions of AD patients. DNA was extracted directly from the dressings and amplified in a specific nested PCR assay. Malassezia-specific DNA was detected in all samples obtained from 32 AD patients. In particular, Malassezia globosa and M. restricta were detected in approximately 90% of the AD patients and M. furfur and M. sympodialis were detected in approximately 40% of the cases. The detection rate was not dependent on the type of skin lesion. In healthy subjects, Malassezia DNA was detected in 78% of the samples, among which M. globosa, M. restricta, and M. sympodialis were detected at frequencies ranging from 44 to 61%, with M. furfur at 11%. The diversity of Malassezia species found in AD patients was greater (2.7 species detected in each individual) than that found in healthy subjects (1.8 species per individual). Our results suggest that M. furfur, M. globosa, M. restricta, and M. sympodialis are common inhabitants of the skin of both AD patients and healthy subjects, while the skin microflora of AD patients shows more diversity than that of healthy subjects. To our knowledge, this is the first report of the use of a nested PCR as an alternative to fungal culture for analysis of the distribution of cutaneous Malassezia spp.


Subject(s)
Dermatitis, Atopic/microbiology , Dermatomycoses/microbiology , Malassezia/classification , Malassezia/genetics , Skin/microbiology , Adult , DNA, Fungal/analysis , Humans , Molecular Sequence Data , Polymerase Chain Reaction/methods , Sensitivity and Specificity
12.
Gut ; 49(3): 324-9, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11511551

ABSTRACT

BACKGROUND: Leptin regulates feeding behaviour and therefore may be a mediator of anorexia associated with acute and chronic inflammation. Recently, leptin mRNA and leptin protein were found in the gastric epithelium. AIM: The aim of the present study was to examine the effect of Helicobacter pylori infection on gastric leptin expression to investigate the pathophysiological role of gastric leptin. METHODS: Surgically resected human stomach tissues were subjected to immunohistochemistry and reverse transcriptase-polymerase chain reaction (RT-PCR) to check for the presence of leptin in the human gastric epithelium. A total of 201 H pylori positive patients with chronic gastritis underwent eradication therapy for H pylori and were examined for the effect of infection cure in terms of body mass index (BMI) and serum leptin levels. Biopsy specimens from the gastric fundic mucosa were obtained from 40 of the 201 patients before and three months after eradication therapy. These samples were subjected to quantitative RT-PCR to examine the effect of eradication therapy on leptin expression in the gastric fundic mucosa. RESULTS: Leptin immunoreactive cells were detected in the lower half of the gastric fundic glands and a leptin PCR product was also found in the gastric fundic mucosa. H pylori infection significantly increased gastric leptin expression. In addition, cure of H pylori infection significantly reduced gastric leptin expression, with a concomitant increase in BMI. In contrast, serum leptin levels did not change significantly after cure of H pylori infection. CONCLUSION: Leptin is present in the human gastric mucosa. Gastric leptin may play a role in weight gain after eradication of H pylori infection. Gastric leptin may have a local rather than systemic action.


Subject(s)
Helicobacter Infections/metabolism , Helicobacter pylori , Leptin/metabolism , Adult , Amoxicillin/therapeutic use , Anti-Ulcer Agents/therapeutic use , Biomarkers , Biopsy , Body Mass Index , Case-Control Studies , Clarithromycin/therapeutic use , Drug Therapy, Combination/therapeutic use , Female , Gastric Mucosa/metabolism , Helicobacter Infections/drug therapy , Humans , Male , Middle Aged , Omeprazole/therapeutic use , Reverse Transcriptase Polymerase Chain Reaction , Statistics, Nonparametric , Stomach Neoplasms/metabolism
13.
Blood ; 98(4): 1127-34, 2001 Aug 15.
Article in English | MEDLINE | ID: mdl-11493461

ABSTRACT

Mast cells (MCs) and eosinophils are thought to play important roles in evoking allergic inflammation. Cell-type--specific gene expression was screened among 12,000 genes in human MCs and eosinophils with the use of high-density oligonucleotide probe arrays. In comparison with other leukocytes, MCs expressed 140 cell-type--specific transcripts, whereas eosinophils expressed only 34. Among the transcripts for expected MC-specific proteins such as tryptase, major basic protein (MBP), which had been thought to be eosinophil specific, was ranked fourth in terms of amounts of increased MC-specific messenger RNA. Mature eosinophils were almost lacking this transcript. MCs obtained from 4 different sources (ie, lung, skin, adult peripheral blood progenitor--derived and cord blood progenitor--derived MCs, and eosinophils) were found to have high protein levels of MBP in their granules with the use of flow cytometric and confocal laser scanning microscopic analyses. The present finding that MCs can produce abundant MBP is crucial because many reports regarding allergic pathogenesis have been based on earlier findings that MBP was almost unique to eosinophils and not produced by MCs. (Blood. 2001;98:1127-1134)


Subject(s)
Eosinophils/metabolism , Gene Expression/genetics , Mast Cells/metabolism , Oligonucleotide Array Sequence Analysis/methods , Ribonucleases , Adult , Blood Proteins/genetics , Blood Proteins/metabolism , Cytoplasmic Granules/chemistry , Eosinophil Granule Proteins , Humans , Immunohistochemistry , Inflammation Mediators/metabolism , Mast Cells/chemistry , Mast Cells/ultrastructure , Proteins/genetics , RNA, Messenger/metabolism , Serine Endopeptidases/genetics , Serine Endopeptidases/metabolism , Tryptases
14.
Int Arch Allergy Immunol ; 125 Suppl 1: 67-70, 2001.
Article in English | MEDLINE | ID: mdl-11408777

ABSTRACT

A cell line, termed NCJ, was established from the bone marrow-derived mast cells (BMMCs) of NC/Nga mice that are mouse models for atopic dermatitis. NCJ cells expressed FcepsilonRI and c-kit and showed a metachromasia of the granules with a toluidine blue-positive and safranin-negative staining pattern that is characteristic for immature-type mast cells. Interestingly, NCJ cells showed proliferation independent of IL-3, which was associated with constitutive phosphorylation of Raf-1 and Erk kinases. Although NCJ cells had several characteristics of mast cells, we failed to detect FcepsilonRI-mediated beta-hexosaminidase release and its histamine content. These findings indicated that NCJ cells represented a mast cell line with an immature phenotype and the ability to proliferate in the absence of mast cell growth factors. NCJ cells might thus be useful to study the molecular basis of mast cell proliferation.


Subject(s)
Cell Line , Mast Cells/cytology , Animals , Cell Division/drug effects , Coloring Agents/chemistry , Dermatitis, Atopic/immunology , Interleukin-3/pharmacology , Male , Mast Cells/metabolism , Mice , Mice, Inbred Strains , Mitogen-Activated Protein Kinases/metabolism , Phenazines/chemistry , Proto-Oncogene Proteins c-raf/metabolism , Tolonium Chloride/chemistry
15.
Aliment Pharmacol Ther ; 15(6): 805-11, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11380318

ABSTRACT

BACKGROUND: The relationship between Helicobacter pylori infection and non-ulcer dyspepsia is still controversial. The potential benefits and risks of the treatment could depend on local conditions, such as the prevalence of the infection and the local rates of gastric cancer. AIM: To evaluate the effects of H. pylori eradication therapy on non-ulcer dyspepsia symptoms in industrial workers in Japan. METHODS: A total of 615 employees of an industrial corporation were examined for H. pylori infection and symptom scores; 215 H. pylori-positive non-ulcer dyspepsia cases underwent eradication therapy. Symptom scores were also analysed 12 months after the eradication therapy. Serum pepsinogen A and pepsinogen C levels were analysed and chronic atrophic gastritis was serologically diagnosed on the basis of the criteria of a pepsinogen A < 70 ng/mL and pepsinogen A : pepsinogen C ratio < 3.0. RESULTS: The symptom score improved significantly in the cured cases, but not in the non-cured cases. The effect of the cure of H. pylori infection on symptoms was analysed according to the serological diagnosis of chronic atrophic gastritis. In both groups, cases with atrophic gastritis and cases with chronic gastritis only, the cure of infection was effective in improving symptoms. CONCLUSION: The cure of H. pylori infection was effective in reducing non-ulcer dyspepsia symptoms in industrial workers in Japan.


Subject(s)
Dyspepsia/drug therapy , Helicobacter Infections/drug therapy , Helicobacter pylori/pathogenicity , Adult , Anti-Bacterial Agents/therapeutic use , Anti-Ulcer Agents/therapeutic use , Dyspepsia/microbiology , Dyspepsia/pathology , Female , Gastritis/etiology , Gastritis/prevention & control , Helicobacter Infections/pathology , Helicobacter pylori/isolation & purification , Humans , Industry , Japan , Male , Middle Aged , Severity of Illness Index , Treatment Outcome
16.
Gut ; 48(5): 605-8, 2001 May.
Article in English | MEDLINE | ID: mdl-11302955

ABSTRACT

BACKGROUND AND AIMS: We previously reported the effect of Helicobacter pylori eradication on hyperammonaemia in patients with liver cirrhosis. However, the role of H pylori as a cause of hyperammonaemia is controversial. We developed an animal model with liver cirrhosis and investigated the effect of H pylori infection on hyperammonaemia. MATERIALS AND METHODS: Five week old male Mongolian gerbils were inoculated orally with broth culture of H pylori. Forty eight gerbils were divided into four groups. Gerbils not inoculated with H pylori were fed a commercial rodent diet (group A) or a choline deficient diet (group C). Gerbils inoculated with H pylori were fed the commercial rodent diet (group B) or the choline deficient diet (group D). Blood ammonia levels of the femoral vein and portal vein were measured 30 weeks later. RESULTS: All gerbils fed the choline deficient diet developed liver cirrhosis with fatty metamorphosis. The survival rate of group D was significantly lower than that of the other groups. Systemic and portal blood ammonia levels in group D were significantly higher than those in the other groups. CONCLUSIONS: H pylori infection induces hyperammonaemia in gerbils with liver cirrhosis.


Subject(s)
Helicobacter Infections/complications , Helicobacter pylori , Hyperammonemia/etiology , Liver Cirrhosis, Experimental/complications , Models, Animal , Animals , Choline Deficiency , Gerbillinae , Helicobacter Infections/metabolism , Helicobacter Infections/pathology , Hepatic Encephalopathy/etiology , Hyperammonemia/metabolism , Hyperammonemia/pathology , Liver Cirrhosis, Experimental/metabolism , Liver Cirrhosis, Experimental/pathology , Male , Prognosis
17.
Br J Dermatol ; 144(1): 12-8, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11167677

ABSTRACT

BACKGROUND: The pathogenesis and aetiology of atopic dermatitis (AD) remain unclear. Establishment of suitable animal models should aid elucidation of the pathogenesis and development of therapy. OBJECTIVES: We focused on biophysical and biochemical parameters in the skin of NC/Nga Tnd mice to evaluate similarities to and differences from AD. METHODS: Biophysical (transepidermal water loss and skin surface conductance) and biochemical parameters (ceramide contents and activity of ceramide-metabolizing enzymes) were measured in NC/Nga Tnd mice in which spontaneous dermatitis appeared under ambient laboratory conditions (ALC). RESULTS: Biophysical parameters suggested impairment of water retention properties and barrier function. The amount of ceramide in NC/Nga Tnd mice under ALC decreased significantly. These dermatological features resembled those of AD, as did the clinical signs and histological changes. CONCLUSIONS: The results described here and previous immunological studies on AD suggest that the NC/Nga Tnd mouse may be a suitable model for certain aspects of AD.


Subject(s)
Dermatitis, Atopic/etiology , Disease Models, Animal , Water Loss, Insensible/physiology , Amidohydrolases/metabolism , Animals , Ceramidases , Ceramides/metabolism , Chromatography, Thin Layer , Dermatitis, Atopic/pathology , Dermatitis, Atopic/physiopathology , Galvanic Skin Response/physiology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred Strains , Skin/metabolism , Sphingomyelin Phosphodiesterase/metabolism
18.
Cytokine ; 13(2): 75-84, 2001 Jan 21.
Article in English | MEDLINE | ID: mdl-11145846

ABSTRACT

Although the functional roles of interleukin (IL-)13 in haematopoietic cells are well investigated, those in non-haematopoietic cells remain to be addressed. IL-13 exerts its actions by binding to the IL-13 receptor (IL-13R) on target cells, which is composed of IL-13Ralpha1 and the IL-4 receptor alpha chain (IL-4Ralpha). However, there has been no study of localization of IL-13R in each tissue. To address this question, we generated monoclonal anti-IL-13Ralpha1 antibody, and performed immunohistochemistry using this antibody and anti-IL-4Ralpha antibody. Distribution of these two components was the same in all examined tissues. Staining was positive in keratinocytes, hair follicles, and sebaceous and sweat glands in skin; in ciliated respiratory epithelial cells in nasal tissue; in heart muscle cells; in foveola cells, gastric glands, and the smooth muscle layer in stomach; and in hepatocytes in liver. However, staining was undetectable in brain and bone marrow. Fibroblasts and endothelial cells were stained in some tissues. These results provide clues to elucidate the known pathological roles of IL-13 in atopic dermatitis and allergic rhinitis, as well as its unknown physiological roles.


Subject(s)
Receptors, Interleukin/biosynthesis , Animals , Antibodies, Monoclonal/metabolism , Blotting, Western , DNA, Complementary/metabolism , Endothelium/metabolism , Fibroblasts/metabolism , Gastric Mucosa/metabolism , Hair Follicle/metabolism , HeLa Cells , Hepatocytes/metabolism , Humans , Hybridomas/metabolism , Immunohistochemistry , Interleukin-13 Receptor alpha1 Subunit , Keratinocytes/metabolism , Muscle, Smooth/metabolism , Myocardium/metabolism , Nasal Mucosa/metabolism , Plasmids/metabolism , Precipitin Tests , Receptors, Interleukin/physiology , Receptors, Interleukin-13 , Receptors, Interleukin-4/biosynthesis , Respiratory Mucosa/metabolism , Sebaceous Glands/metabolism , Skin/metabolism , Sweat Glands/metabolism , Tissue Distribution
19.
Arerugi ; 50(12): 1152-62, 2001 Dec.
Article in Japanese | MEDLINE | ID: mdl-11830999

ABSTRACT

NC/Nga mouse is well known as a mouse model for atopic dermatitis. In general, when NC/Nga mouse are raised under specific pathogen free (SPF) conditions no skin lesions are detected, but when under non-filtrated (conventional) condition, atopic dermatitis like skin lesions appear spontaneously. However, this dermatitis develops in 70-90% of mice (not 100%), which makes it difficult to perform reproducible experiments every time. This study was performed under SPF conditions, using the four solutions (2% SDS, 4% SDS, ethanol, acetone/ether) to destroy the skin barrier function, and thereafter, applying the extracted solution of mite: Dermatophagoides pteronyssinus, which is a very popular antigen in pathogenesis of human atopic dermatitis. The extracted solution of mite was applied repeatedly on the NC/Nga mice with a pretreatment of barrier destroying solution and after 8 weeks the mice developed severe dermatitis (clinical skin condition score of 7-10.2 points) with marked elevation of plasma IgE level, whereas mice coated only with the barrier destroying solution showed weak skin lesion with no elevation of plasma IgE level. BALB/c mice, which are employed as control, showed weak skin lesion (clinical skin condition score of 0-3.8 points) and slight elevation of plasma IgE level after repeated application of the extracted solution of mite with a pretreatment of the barrier destroying solution, whereas mice coated only with the barrier destroying solution showed weak skin lesion and the no elevation of plasma IgE level was observed. In this study, using several solutions to disturb the skin barrier function before applying the antigen, we have found a suitable condition and types of solutions in inducing dermatitis in NC/Nga mice.


Subject(s)
Dermatitis, Atopic/etiology , Skin/pathology , Acetone/pharmacology , Animals , Dermatitis, Atopic/pathology , Disease Models, Animal , Ethanol/pharmacology , Female , Mice , Mice, Inbred BALB C , Skin/drug effects
20.
Clin Immunol ; 95(3): 190-6, 2000 Jun.
Article in English | MEDLINE | ID: mdl-10866125

ABSTRACT

Binding of IgE to the high-affinity IgE receptor (Fc(epsilon)RI) is the essential event for allergic reaction. Although there are many reports on binding kinetics between myeloma IgE and Fc(epsilon)RI, little is known about the kinetics between heterogeneous polyclonal IgE in the serum and Fc(epsilon)RIalpha. To elucidate the binding characteristics of heterogeneous serum IgE, we measured kinetic parameters of binding between IgE from allergic patients and a recombinant ectodomain of the human Fc(epsilon)RIalpha subunit by real-time interaction analysis based on surface plasmon resonance. Purified IgE monomer from the plasma of allergic patients displayed kinetics for the interaction with Fc(epsilon)RIalpha similar to those of myeloma IgE. In the case of crude IgE samples from allergic patients, one of seven specimens showed significantly higher affinity than highly purified IgE, suggesting that it is possible for IgEs in this specimen to form complexes of higher molecular weight.


Subject(s)
Dermatitis, Atopic/blood , Immunoglobulin E/blood , Receptors, IgE/blood , Humans , Kinetics , Protein Binding , Recombinant Proteins/blood , Solubility
SELECTION OF CITATIONS
SEARCH DETAIL
...